These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38779591)
1. A bioactive nanocomposite integrated specific TAMs target and synergistic TAMs repolarization for effective cancer immunotherapy. Gu W; Guo W; Ren Z; Zhang Y; Han M; Zhao Q; Gao Y; Mao Y; Wang S Bioact Mater; 2024 Aug; 38():472-485. PubMed ID: 38779591 [TBL] [Abstract][Full Text] [Related]
2. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy. Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy. Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878 [TBL] [Abstract][Full Text] [Related]
4. Mechanism exploration of synergistic photo-immunotherapy strategy based on a novel exosome-like nanosystem for remodeling the immune microenvironment of HCC. Chen Y; Li X; Shang H; Sun Y; Wang C; Wang X; Tian H; Yang H; Zhang L; Deng L; Yang K; Wu B; Cheng W Nano Converg; 2024 Aug; 11(1):31. PubMed ID: 39141072 [TBL] [Abstract][Full Text] [Related]
5. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy. Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016 [TBL] [Abstract][Full Text] [Related]
6. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles. Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987 [TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579 [No Abstract] [Full Text] [Related]
8. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction. Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192 [TBL] [Abstract][Full Text] [Related]
9. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer. Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096 [TBL] [Abstract][Full Text] [Related]
10. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy. Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762 [TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy. Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974 [TBL] [Abstract][Full Text] [Related]
12. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy. Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808 [TBL] [Abstract][Full Text] [Related]
14. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation. Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328 [TBL] [Abstract][Full Text] [Related]
15. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy. Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417 [TBL] [Abstract][Full Text] [Related]
16. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages. Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523 [TBL] [Abstract][Full Text] [Related]
17. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053 [TBL] [Abstract][Full Text] [Related]
18. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects. Xiao H; Guo Y; Li B; Li X; Wang Y; Han S; Cheng D; Shuai X ACS Cent Sci; 2020 Jul; 6(7):1208-1222. PubMed ID: 32724855 [TBL] [Abstract][Full Text] [Related]
19. ROS-Inducing Micelles Sensitize Tumor-Associated Macrophages to TLR3 Stimulation for Potent Immunotherapy. Liu L; He H; Liang R; Yi H; Meng X; Chen Z; Pan H; Ma Y; Cai L Biomacromolecules; 2018 Jun; 19(6):2146-2155. PubMed ID: 29669207 [TBL] [Abstract][Full Text] [Related]
20. Biodegradable mesoporous nanocomposites with dual-targeting function for enhanced anti-tumor therapy. Gao S; Liu Y; Liu M; Yang D; Zhang M; Shi K J Control Release; 2022 Jan; 341():383-398. PubMed ID: 34863841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]